Chenqiu Wang

Jan 9, 2025 | onlinelibrary.wiley.com | Tianjian Laboratory |Fang Li |Dongdong Jian |Chenqiu Wang

1 Introduction The survival rate of cancer patients has significantly improved with the use of various chemotherapeutic drugs. However, the cardiotoxic adverse reactions associated with the use of chemotherapeutic drugs have become increasingly apparent. In addition to limiting the effectiveness of cancer treatment, these adverse reactions also severely affect the quality of life of cancer patients [1].